Sabby Management’s BIO-key International BKYI Stock Holding History

Sabby Management’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6	Closed	-$253K	–	131
2022 Q1	$253K	Sell	6 -2	-25%	-$808	0.04%	92
2021 Q4	$324K	Sell	8 -1	-11%	-$505	0.05%	124
2021 Q3	$571K	Hold	9	–	–	0.08%	113
2021 Q2	$603K	Hold	9	–	–	0.09%	102
2021 Q1	$547K	Buy	+9	New	+$6.5K	0.11%	105

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sabby Management's BKYI Position: Q2 2022 in Review

Sabby Management sold out of BIO-key International (BKYI) in Q2 2022, closing a stake of 243 shares — an estimated $105K sold.

Sabby Management first reported a position in BKYI in Q3 2020 and held it in 6 quarters. The position peaked at $117K in Q1 2021. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2022.

Sabby Management reported no remaining BIO-key International position as of Q2 2022 after selling out during the quarter.
Sabby Management sold 243 BIO-key International shares in Q2 2022, an estimated $105K.
Sabby Management first reported a position in BIO-key International in Q3 2020 and held it in 6 quarters.
Sabby Management's BIO-key International position peaked at $117K in Q1 2021.
8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2022.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.